Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sinovac’s chickenpox vaccine shows 87% efficacy in topline phase 3
Sinovac’s chickenpox vaccine shows 87% efficacy in topline phase 3
Sinovac’s chickenpox vaccine shows 87% efficacy in topline phase 3
Submitted by
admin
on September 26, 2017 - 9:43pm
Source:
Fierce Pharma
News Tags:
Sinovac
vaccines
chicken pox
varicella zoster
Headline:
Sinovac’s chickenpox vaccine shows 87% efficacy in topline phase 3
Do Not Allow Advertisers to Use My Personal information
